Registry of long-term antithrombotic therapy for coronary artery disease
Official title: Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndromes
Run by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · NCT04347200 · Data updated 2026-11-12
This study looks at how safe and effective long-term blood-thinning treatments are for people with coronary artery disease, including those who have had heart attacks or heart surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Government |
| Locations | 1 site (Moscow) |
| Status | Recruiting |
| Started | January 15, 2015 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT04347200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with confirmed coronary artery disease who require long-term antithrombotic therapy.
✕Probably not a fit
Patients with acute coronary syndrome within the past 12 months or severe comorbid conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the rates of ischemic and hemorrhagic complications associated with long-term antithrombotic therapy in patients suffering from chronic coronary syndromes. Conducted at a single center in Russia, it focuses on individuals with confirmed coronary artery disease, including those with a history of myocardial infarction or revascularization. The study will collect data on the effectiveness and safety of antiplatelet drugs over an extended period.
Why it matters
Potential benefit: If successful, this study could improve the management and safety of antithrombotic therapy in patients with coronary artery disease.
How similar studies have gone: Other studies have shown varying degrees of success with long-term antithrombotic therapy in similar patient populations, but this specific registry approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging Exclusion Criteria: * Subjects who are unwilling or unable to provide informed consent. * Acute coronary syndrome within 12 months before inclusion * Severe chronic heart failure (NYHA IV) * Stroke within 6 months before inclusion * Severe liver or muscle disease * Severe kidney disease / renal failure with creatinine \> 3 mg/dl * Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -
Where it's running
-
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Moscow, Russia Recruiting
Study contacts
- Principal investigator: Elizaveta Panchenko, PhD — National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Study coordinator: Andrey Komarov, PhD
- Email: andrkomarov@mail.ru
- Phone: +79161813257
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events
In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.
-
Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD
This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.
-
Super-resolution ultrasound imaging for peripheral artery disease
This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.
-
Obstructive sleep apnea prevalence in people with peripheral artery disease
This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.
-
Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better
This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.
-
Evaluating a Paclitaxel Coated Balloon for Treating Atherosclerosis in Leg Arteries
This study is testing a special balloon treatment to see if it can safely improve blood flow and reduce symptoms in people with blocked leg arteries due to peripheral artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.